GL1X · GenesisL1 explorer

Research workbench

Benzofuropyrimidinone inhibitors of pim-1

Analyse Benzofuropyrimidinone inhibitors of pim-1 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4ALV
Type
protein
Length
274 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase pim-1
EC
2.7.1.37, 2.7.11.1
UniProt
P11309
Ligands
R9P
Pockets
2 · best druggability 0.66

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 23% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ASERINE/THREONINE-protein kinase pim-1 (EC 2.7.1.37, 2.7.11.1)protein27437% helix, 23% strandP11309

Ligands and binding sites

  • R9P · 8-bromo-2-{2-chloro-4-[(piperidin-4-ylmethyl)amino]phenyl}[1]benzofuro[3,2-d]pyrimidin-4(3H)-one · ligand · chains A
  • IMD · Imidazole · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12260.660.8325R9P
2970.490.8224empty

Compared structures

  • 4ALV · Benzofuropyrimidi Inhibitors of Pim-1 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.